Clinical Decision Support systems are software tools built into electronic health records that help doctors in real time. These systems look at patient information and give reminders, alerts, or advice to help with treatment decisions. When designed well, CDS tools make work easier, reduce mistakes, and help follow medical guidelines.
For opioid use disorder, CDS can help busy emergency doctors find patients at risk, check withdrawal signs, and start treatments like buprenorphine or give naloxone to prevent overdoses. But how well these tools work depends a lot on how easy they are to use and fit into daily work.
The EMBED project, led by Dr. Edward Melnick and his team, was a practical trial done from November 2019 to May 2021 across 18 emergency department groups in five health systems. The goal was to use a CDS system that helps start buprenorphine treatment for patients with opioid use disorder in the ED.
The system was built into electronic health records and aimed to get doctors more involved with proven treatments. Of 5,047 patients with OUD, 2,787 got care with the CDS tool, while 2,260 got usual care. Starting buprenorphine was about the same between groups (12.5% vs. 12.0%), but more doctors used the treatment in the CDS group (44.4% vs. 34.0%).
Dr. Gail D’Onofrio, who worked on the trial, said that designing the system for users helped doctors use it more, even if overall treatment rates didn’t change much. The study shows that CDS tools can get doctors to try new treatments, but patient-level challenges still exist.
Another study by Dr. Margaret Lowenstein looked at a nurse-led screening question plus EHR prompts to check for opioid withdrawal and start treatment. This was done in three urban academic emergency departments. The approach helped find patients with opioid use disorder more reliably and guided care decisions.
The study found a 17% rise in withdrawal assessments using the Clinical Opioid Withdrawal Scale in EDs with the protocol compared to those without. Buprenorphine prescriptions when patients left the ED went up by 5%, and naloxone prescriptions rose by 12 percentage points.
This study shows how making screening and treatment normal parts of emergency care can reduce differences in care and help more patients get the right treatment on time.
A third study by Jacob A. Lebin tested a CDS tool that gave interruptive alerts in the electronic health record at an urban academic ED from May 2022 to November 2023. The tool used rules to send alerts for patients possibly at risk for opioid use disorder based on usual EHR data.
The alerts showed up in 4.7% of ED visits, involving 2,566 patients and 116 emergency providers. Doctors acted on the alerts in 27% of cases, accessing treatment plans or calling social work. Buprenorphine use went up by 31%, prescribing rose by 20%, and filled prescriptions at pharmacies attached to the hospital increased by 17%.
Lebin and his team said that while interruptive alerts can cause alert fatigue, they seemed better than passive ones at getting doctors to act and improving treatment.
Using artificial intelligence (AI) and workflow automation in clinical decision support can make emergency care for opioid use disorder easier and more steady. AI looks at lots of patient data fast to find who is at risk, check withdrawal signs, and suggest treatments.
These AI-powered CDS tools usually:
For medical leaders and IT managers, using AI-driven CDS means less manual screening and simpler treatment decisions. Automated systems reduce missed cases and delays by building best practices into daily work.
Also, prompts given at the moment of care help clinicians deal with busy ED environments where time is short and many tasks compete. Designing these AI tools to fit clinician needs and workflow is key so they support care instead of getting in the way.
Adding AI into electronic health records can improve finding opioid use disorder, increase starting treatments like buprenorphine, and make sure naloxone is prescribed. These systems help create standard care paths that follow national goals to address the opioid crisis.
Medical practice administrators, owners, and IT managers in the U.S. should think about these points when choosing user-centered clinical decision support systems:
User-centered clinical decision support systems in emergency departments have helped find and treat opioid use disorder better in several U.S. studies. Though patient treatment rates still need improvement, these tools have helped doctors use proven treatments more, made screening consistent, and supported automated workflows to guide care.
For healthcare leaders managing medical practices and emergency departments, adopting AI-enhanced CDS tools is a good way to help doctors handle opioid issues despite busy emergency settings. Careful planning and involving clinicians can lead to more regular use of treatments like buprenorphine and naloxone. This can lower sickness and death from opioids in many communities.
The EMBED trial is a pragmatic cluster randomized controlled study designed to implement emergency department-initiated buprenorphine for patients with opioid use disorder, integrating a user-centered clinical decision support system into electronic health records (EHR).
The trial aimed to tackle the poor usability of health information technology as a barrier to implementing evidence-based medicine in emergency departments.
Eighteen emergency department clusters across five healthcare systems in five states participated in the study.
The primary outcome was the rate of buprenorphine administration or prescription in the emergency department for patients with opioid use disorder.
Secondary implementation outcomes were measured using the RE-AIM framework, focusing on reach, effectiveness, adoption, implementation, and maintenance.
While patient-level rates of buprenorphine initiation did not increase significantly, clinician engagement showed improvement, with a higher proportion of physicians initiating treatment in the intervention arm.
A user-centered clinical decision support system is designed to enhance the clinician’s workflow, aiding in diagnosis, treatment decisions, and automating documentation within EHR.
The RE-AIM framework evaluates the reach of an intervention, its effectiveness, the adoption rate, the implementation process, and the sustainability of the intervention results.
The EMBED trial contributed to an increase in the number of unique physicians who initiated buprenorphine and prescribed naloxone in the emergency department.
The trial’s results underscore the importance of user-centered design in clinical decision support systems to enhance clinician adoption of complex medical practices, especially in emergency settings.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
